Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure (CoVa)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02368184|
Recruitment Status : Withdrawn (Sponsor decided not to go forward with study. No subjects were enrolled.)
First Posted : February 20, 2015
Last Update Posted : May 25, 2016
|Condition or disease|
|Congestive Heart Failure|
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure|
|Study Start Date :||February 2015|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||May 2016|
- Track physiologic parameters among patients with ADHF and explore predictive algorithms to allow for early ID of patients at risk of ADHF. [ Time Frame: 65 days ]
- To track on a daily basis important physiologic parameters among patients with a primary diagnosis of acute decompensated heart failure (ADHF) beginning at the time of their hospitalization and then continued for up to 60 days after discharge, in order to better understand their inter- and intra- individual variability and compare this to standard monitoring including daily weights.
- To explore the development of predictive algorithms to allow for the early identification of patients at risk of acute decompensation and/or HF hospitalization.
- Compare transthoracic impedance in individuals who already have a Medtronic implanted device with OptiVol technology. [ Time Frame: 65 days ]Compare transthoracic impedance measured noninvasively with the CoVa and invasively in individuals who already have a Medtronic implanted device with OptiVol technology.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02368184
|United States, California|
|San Diego, California, United States, 92037|
|Principal Investigator:||Steven Steinhuble, MD||Scripps Translational Science Institute|